Listen on the go
CORRECT!
Next question
touchONCOLOGY touchONCOLOGY
Supportive Cancer Care

Nicolò Matteo Luca Battisti, European Cancer Summit 2020 – Inequalities in Cancer Care

Copy Link
Published Online: Dec 17th 2020

Discrimination in cancer care is a major ongoing issue across Europe and has been exacerbated during the COVID-19 pandemic. Nicolò Matteo Luca Battisti discusses how the resolution from this year’s European Cancer Summit will help overcome these disparities.

Questions

  1. Could you give us an overview of the issue of discrimination in cancer care?
  2. What are the major disparities in cancer care across Europe?
  3. How is the COVID-19 pandemic affecting these disparities?
  4. How can we achieve policy change to combat disparities and discrimination?
  5. What was the resolution of this year’s European Cancer Summit on this issue?

Speaker Disclosures: Nicolò Matteo Luca Battisti has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of the European Cancer Summit 2020.

Share this Video
Related Videos In Supportive Cancer Care
Supportive Cancer Care
Professor D’Ugo: Don’t Miss Out on Registering for the ESSO 40!

Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO), shares what we can look forward to at the annual meeting in November!

Supportive Cancer Care
Domenico D’Ugo, ESSO 40: Hot Topics, What to Expect and Why Should HCPs Register

touchONCOLOGY were delighted to speak with Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our media partners. He discusses why healthcare professionals should register and attend the ESSO 40 conference in November 2021 in Lisbon and what we can look forward to. Questions 1. What can we expect from ESSO […]

Supportive Cancer Care
Professor Domenico D’Ugo: Current Initiatives at ESSO and Looking to the Future

Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our valued media partners at touchONCOLOGY, discusses the latest from the society and his hopes for oncology management post-COVID19 in 2022. Questions 1. Please tell us about any initiatives that ESSO are currently working on? (00:15-02:24) 2. What can we expect in […]

Trending In Supportive Cancer Care:

Professor D’Ugo: Don’t Miss Out on Registering for the ESSO 40!
Supportive Cancer Care
    • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72